QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: QG101-23-0 capsulesDrug: Placebo
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Amckaus PTY LTD.
- Target Recruit Count
- 78
- Registration Number
- NCT05650528
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, Australia
Aom0319 SAD Study in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: 0.9% Sodium Chloride Injection
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Amckaus PTY LTD.
- Target Recruit Count
- 38
- Registration Number
- NCT05555758
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Australia
© Copyright 2025. All Rights Reserved by MedPath